Organisation: Luxembourg Centre for Systems Biomedicine (LCSB)
-
News
Investigating the modulation of the COVID-19 immune response
Learn moreIn a recent paper, the research team around Prof. Antonio del Sol from the University’s Luxembourg Centre for Systems Biomedicine (LCSB) describes a new method of how molecules can be identified that amplify and maintain the inflammatory response upon an infection. They use their novel method to identify these molecules in COVID-19 patients and suggest…
-
News
University and LIH translate research into clinical development
Learn moreThe COVID-19 pandemic has shown that conducting strong translational research is key to combating the coronavirus. By leveraging cutting edge laboratory techniques to study patient samples, translational research quickly pivots laboratory discoveries into new therapies for patients, in a process known as the bench-to-bedside approach. Luxembourg has established excellent transversal and translational research, spanning several…
-
News
LCSB partners with SciCrunch to promote reproducibility of research
Learn moreAs part of a broad initiative aiming to guarantee research quality and reproducibility of scientific results, the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg is partnering with SciCrunch Inc. The LCSB will be one of the first academic institutions to use SciScore – an automated validation tool for scientific articles –…
-
News
pdp 2.0: Individually tailored dementia prevention
Learn moreIn Luxembourg, more people shall be able to reduce their risk of developing dementia
-
News
New study highlights links between inflammation & Parkinson’s disease
Learn moreAn international collaboration involving researchers from the Luxembourg Centre for Systems Biology (LCSB) at the University of Luxembourg established an association between inflammation and specific genetic mutations in Parkinson’s patients. The study, recently published in the scientific journal Brain, highlights two biomarkers that could be used to assess Parkinson’s disease state and progression. The results…
-
News
New approach against Parkinson’s disease through stem cell research
Learn moreIn a seven-year research effort, an international team of scientists has clarified the cause for certain genetic forms of Parkinson’s disease, and has identified potential pharmacological treatments. The interdisciplinary research team, led by Prof. Rejko Krüger, of the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, experimented on patient-based cell cultures in…